Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gian Matteo Rigolin
“Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated With Chemotherapy With or Without Immunotherapy.”
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Related publications
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors
Turkish Journal of Haematology
Hematology
Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide
Clinical Journal of Oncology Nursing
Oncology
Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prognostic/Predictive Value of 207 Serum Factors in Colorectal Cancer Treated With Cediranib and/or Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Prognostic Factors Associated With a Stable MR4.5 Achievement in Chronic Myeloid Leukemia Patients Treated With Imatinib
Oncotarget
Oncology
Comparative Efficacy of Chronic Lymphocytic Leukemia Treatment With or Without Rituximab
Oncogematologiya
Oncology
Hematology
Risk Factors for Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With the Cyclin-Dependent Kinase Inhibitor, Flavopiridol
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
Comment on Lipsky Et Al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
Haematologica
Hematology
